TNF and caspase-8-mediated control of Legionella pneumophila infection

TNF 和 caspase-8 介导的嗜肺军团菌感染控制

基本信息

  • 批准号:
    10364637
  • 负责人:
  • 金额:
    $ 24.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-05 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

Project Summary Intracellular bacterial pathogens such as Legionella pneumophila, the causative agent of the severe pneumonia Legionnaires' disease, are responsible for significant disease burden in the United States every year. Successful control of Legionella and other intracellular bacterial pathogens requires a robust immune response that allows for production of inflammatory cytokines, such as Tumor Necrosis Factor (TNF), that enables macrophages to restrict intracellular bacterial replication. TNF is required for host defense against Legionella and other pathogens in mouse models of infection. TNF is also critical for the control of Legionella and other intracellular pathogens in humans, as patients taking TNF blockers to treat inflammatory disorders such as rheumatoid arthritis or ulcerative colitis are at increased risk of acquiring Legionnaires' disease and other bacterial infections. However, the precise molecular and cellular mechanisms by which TNF mediates anti-bacterial defense are still unclear. Our new preliminary data indicate that that TNF promotes caspase-8- dependent cell death during Legionella infection, and that mice and macrophages deficient for caspase-8 are defective in controlling Legionella infection. These new data provoke the hypothesis that TNF promotes caspase-8-dependent apoptosis of infected macrophages to restrict Legionella infection. Thus, Aim 1 seeks to test the hypothesis that TNF induces caspase-8-mediated death of infected macrophages to restrict intracellular bacterial replication. Aim 2 will test the hypothesis that TNF- and caspase-8-mediated death of infected alveolar macrophages promotes host control of pulmonary Legionella infection. These studies will provide fundamental insight into how TNF mediates immune control of intracellular bacterial infection, and may provide a basis for the development of improved therapeutics for the treatment of Legionella and other bacterial infections.
项目摘要 细胞内的细菌病原体,如嗜肺军团菌,严重的 肺炎军团病,是美国每年造成重大疾病负担的疾病之一 年。成功控制军团菌和其他细胞内细菌病原体需要强大的免疫力 允许产生炎性细胞因子的反应,如肿瘤坏死因子 使巨噬细胞能够限制细胞内的细菌复制。宿主防御需要肿瘤坏死因子 军团菌和其他病原体在小鼠模型中的感染。肿瘤坏死因子对军团菌的控制也至关重要 以及其他细胞内病原体,因为患者服用肿瘤坏死因子阻滞剂治疗炎症性疾病 例如类风湿性关节炎或溃疡性结肠炎患退伍军人症的风险增加,以及 其他细菌感染。然而,肿瘤坏死因子介导的确切分子和细胞机制 抗菌防御仍不清楚。我们的新的初步数据表明,肿瘤坏死因子促进caspase-8- 军团菌感染过程中依赖的细胞死亡,以及缺乏caspase-8的小鼠和巨噬细胞 在控制军团菌感染方面存在缺陷。这些新数据引发了一种假设,即肿瘤坏死因子促进 依赖caspase-8的巨噬细胞凋亡抑制军团菌感染。因此,目标1寻求 验证肿瘤坏死因子诱导caspase-8介导的感染巨噬细胞死亡的假说 细胞内细菌复制。目的2将测试假设,肿瘤坏死因子和半胱氨酸天冬氨酸氨基转移酶-8介导的死亡 感染的肺泡巨噬细胞促进宿主控制肺军团菌感染。这些研究将 提供了关于肿瘤坏死因子如何介导细胞内细菌感染的免疫控制的基本见解,并可能 为开发治疗军团菌和其他疾病的改进疗法提供依据 细菌感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sunny Shin其他文献

Sunny Shin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sunny Shin', 18)}}的其他基金

Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
  • 批准号:
    10753211
  • 财政年份:
    2023
  • 资助金额:
    $ 24.38万
  • 项目类别:
Defining human noncanonical inflammasome responses to Legionella pneumophila
定义人类对嗜肺军团菌的非典型炎症反应
  • 批准号:
    9214308
  • 财政年份:
    2016
  • 资助金额:
    $ 24.38万
  • 项目类别:
Defining human noncanonical inflammasome responses to Legionella pneumophila
定义人类对嗜肺军团菌的非典型炎症反应
  • 批准号:
    9079707
  • 财政年份:
    2016
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    10867793
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    10675707
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    9180679
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    9378776
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    9052504
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    10317640
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:
Innate immune-mediated control of pulmonary Legionella pneumophila infection
先天免疫介导控制肺部嗜肺军团菌感染
  • 批准号:
    10437007
  • 财政年份:
    2015
  • 资助金额:
    $ 24.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了